THE PROBLEM
“A post-antibiotic era—in which common infections and minor injuries can kill is a very real possibility.”
— World Health Organization, 2014
THE SOLUTION
Atterx is developing products which treat drug-resistant pathogens:
C-1205:
Catheter Associated Urinary Tract Infections
GN-4474:
Gram Negative Bacterial Infections
Annual deaths due to antimicrobial resistance expected to rise dramatically by 2050
Atterx is developing products to address this threat
